Dr. Sabel’s research interests focus on the immune response to cancer cell death, particularly after cryoablation (freezing) of cancer, and he is an internationally recognized expert in the field of cryo-immunology. He also has several clinical trials examining cryoablation of breast cancer. Dr. Sabel’s lab is also focused on the identification of prognostic and predictive markers in oncology, using both serum proteomic and tissue microarray approaches, to help guide surgical and adjuvant therapy.